Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2019

Conditions
Coronary Heart DiseaseMetabolic SyndromeDiabetes Mellitus
Interventions
RADIATION

PET scan

A cardiac PET scan will be performed at baseline (main CIRT trial randomization) and at 12-months.

RADIATION

Echocardiogram

An echocardiogram will be performed at baseline (main CIRT trial randomization) and at 12-months.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Ottawa Heart Institute Research Corporation

OTHER

collaborator

University of Alabama at Birmingham

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT02786134 - Coronary Flow Reserve to Assess Cardiovascular Inflammation (CIRT-CFR) | Biotech Hunter | Biotech Hunter